Speaker illustration

Doctor Moritz Messner

Innsbruck Medical University, Innsbruck (Austria)

Member of:

European Society of Cardiology
Heart Failure Association

Write your professional biography here ...

Smooth muscle cell specific ablation of CXCL12 downregulates endothelial CXCR7 leading to defective coronary arteries and cardiac hypertrophy

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiac Hypertrophy

Session: Basic science e-posters


Loss of smooth muscle SDF-1/CXCL12 leads to cardiac hypertrophy and aortic valve stenosis

Event: ESC Congress 2020

Topic: Cardiac Diseases

Session: Cellular Pathomechanisms of Cardiac Remodeling


Conditional ablation of SDF-1/CXCL12 in smooth muscle cells leads to severe cardiac hypertrophy and aortic valve stenosis

Event: ESC Congress 2019

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Cellular cross talk in heart failure


Smooth muscle cell specific SDF-1/CXCL12 KO mice display severe cardiac hypertrophy and vascular defects

Event: ESC Congress 2018

Topic: Cardiac Hypertrophy

Session: Signal transduction in cardiac disease


LMNA splice variant progerin is upregulated in dilated cardiomyopathy

Event: Heart Failure 2018

Topic: Genetics, Epigenetics, ncRNA

Session: Basic Science - Cardiac Biology and Physiology


Upregulation of the aging related LMNA splice variant progerin in cardiomyopathy

Event: ESC Congress 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy


The aging related splice variant progerin upregulated in cardiomyopathy hearts

Event: ESC Congress 2016

Topic: Premature cardiovascular ageing

Session: Premature ageing: what do we know?


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb